Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemiaAkihiro Ohmoto, Hermann Einsele, Shigeo Fuji et al.|Bone Marrow Transplantation|2022Cited by 18
Outcomes and Predictors of Early Infection after Heart TransplantationKendall C. Shultes, Bethany R Tellor Pennington, Jerrica E. Shuster et al.|Surgical Infections|2018Cited by 16
Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantationJana Sawyer, Kendall C. Shultes, Taylor Elliott et al.|Clinical Hematology International|2024Cited by 9
Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell TransplantationKendall C. Shultes, Sean DeFrates, Christopher J. Arp et al.|Biology of Blood and Marrow Transplantation|2017Cited by 6
Impact of Granulocyte Colony Stimulating Factor Use Following CD-19 Chimeric Antigen Receptor T-Cell TherapyMarshall Winget, Lindsay Orton, Salyka Sengsayadeth et al.|Transplantation and Cellular Therapy|2025Cited by 3